Stryker Corporation Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Stryker Corporation on January 24, 2025, with the earliest event reported on January 28, 2025. The filing discloses significant changes in executive leadership, specifically the departure of the Chief Financial Officer and the appointment of a successor.
Key Financial Metrics
This filing does not contain revenue, profit, cash flow, margin, debt, or liquidity metrics. The document focuses exclusively on executive compensation arrangements and personnel changes.
Material Changes
- Executive Departure: Glenn S. Boehnlein will retire as Vice President and Chief Financial Officer effective April 1, 2025.
- Executive Appointment: Preston W. Wells, currently Vice President, Group Chief Financial Officer for Orthopaedics, has been promoted to Vice President and Chief Financial Officer effective April 1, 2025.
- Compensation Adjustments:
- Mr. Boehnlein: Will serve as an Advisor to the CEO until March 31, 2026, receiving a base salary of $800,000 annually, eligibility for a 2025 incentive bonus (target 100% of salary), and a specific transition incentive bonus of $215,000 contingent on remaining employed through the advisory period.
- Mr. Wells: Annualized base salary will increase to $725,000 effective April 1, 2025. His bonus target is set at 85% of his annual base salary. A recommendation will be made for long-term incentive awards with an aggregate target value of approximately $3,000,000 (40% stock options, 60% performance stock units).
Guidance, Outlook, and Risks
The filing does not provide financial guidance, outlook, or management commentary on business performance. It notes that there are no family relationships between Mr. Wells and any director or executive officer, and no arrangements exist regarding his selection other than the disclosed compensation agreements. The filing includes a Regulation FD disclosure referencing a press release issued on January 28, 2025.
Investor Verification Checklist
- Verify the effective date of the CFO transition (April 1, 2025) and the duration of the outgoing CFO's advisory role.
- Review the full text of the Transition Agreement (Exhibit 10.1) and Letter Agreement (Exhibit 10.2) for detailed terms regarding equity vesting and performance goals.
- Confirm the specific performance metrics attached to Mr. Wells' proposed $3,000,000 long-term incentive award once approved by the Compensation Committee.
- Monitor future filings for any impact on financial reporting timelines or strategy resulting from the leadership change.